Michel Kuzur | Biological Therapy/Immunotherapy Chemotherapy Pain Management Photodynamic Therapy Targeted Therapy

Michel Kuzur, MD

Medical Oncologist

Conditions Treated

Laryngeal Cancer Lung Cancer Ovarian Cancer

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Pain Management Photodynamic Therapy Targeted Therapy

Hospitals & Clinics

Bio & Insurance Information

Insurance Accepted

Aetna Choice POS II Aetna HMO

Education & Training

of Massachussetts Memorial Healthcare

Residency

Vanderbilt University

Fellowship

American University of Beirut Faculty of Medicine

Medical School

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Hematology

American Board of Internal Medicine - Oncology

Medical License

TN State Medical License Active through 2018

Hospitals & Clinics

Publications

Dr. Michel Kuzur has contributed to 3 publications.

Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network

Greco, F.A., Spigel, D.R., Kuzur, M.E., Shipley, D., Gray, J.R., Thompson, D.S., Burris, H.A., Yardley, D.A., Pati, A., Webb, C.D., Gandhi, J.G., Hainsworth, J.D.; Clin Lung Cancer. 2007 Sep.

Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial.

Hainsworth, J.D., Spigel, D.R., Raefsky, E.L., Kuzur, M.E., Yost, K., Kommor, M., Litchy, S., Greco, F.A.; Cancer. 2005 Nov 1.

Phase I. Trial of irinotecan plus carboplatin in two dose schedules.

Jones, S.F., Burris, H.A., Hainsworth, J.D., Yardley, D.A., Raefsky, E.A., Miranda, F.T., Kuzur, M.E., Willcutt, N.T., White, M.B., Greco, F.A.; Oncology (Williston Park). 2003 May.